172 related articles for article (PubMed ID: 29399118)
1. Epidermal growth factor receptor aptamer-conjugated polymer-lipid hybrid nanoparticles enhance salinomycin delivery to osteosarcoma and cancer stem cells.
Yu Z; Chen F; Qi X; Dong Y; Zhang Y; Ge Z; Cai G; Zhang X
Exp Ther Med; 2018 Feb; 15(2):1247-1256. PubMed ID: 29399118
[TBL] [Abstract][Full Text] [Related]
2. Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells.
Ni M; Xiong M; Zhang X; Cai G; Chen H; Zeng Q; Yu Z
Int J Nanomedicine; 2015; 10():2537-54. PubMed ID: 25848270
[TBL] [Abstract][Full Text] [Related]
3. Promoted Delivery of Salinomycin to Lung Cancer Through Epidermal Growth Factor Receptor Aptamers Coupled DSPE-PEG2000 Nanomicelles.
Leng D; Hu J; Huang X; He W; Wang Y; Liu M
J Nanosci Nanotechnol; 2018 Aug; 18(8):5242-5251. PubMed ID: 29458573
[TBL] [Abstract][Full Text] [Related]
4. Targeted salinomycin delivery with EGFR and CD133 aptamers based dual-ligand lipid-polymer nanoparticles to both osteosarcoma cells and cancer stem cells.
Chen F; Zeng Y; Qi X; Chen Y; Ge Z; Jiang Z; Zhang X; Dong Y; Chen H; Yu Z
Nanomedicine; 2018 Oct; 14(7):2115-2127. PubMed ID: 29898423
[TBL] [Abstract][Full Text] [Related]
5. Salinomycin-loaded lipid-polymer nanoparticles with anti-CD20 aptamers selectively suppress human CD20+ melanoma stem cells.
Zeng YB; Yu ZC; He YN; Zhang T; Du LB; Dong YM; Chen HW; Zhang YY; Wang WQ
Acta Pharmacol Sin; 2018 Feb; 39(2):261-274. PubMed ID: 29388568
[TBL] [Abstract][Full Text] [Related]
6. Polymer-lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells.
Li J; Xu W; Yuan X; Chen H; Song H; Wang B; Han J
Int J Nanomedicine; 2017; 12():6909-6921. PubMed ID: 29075110
[TBL] [Abstract][Full Text] [Related]
7. The enhanced delivery of salinomycin to CD133
Mi Y; Huang Y; Deng J
Oncol Lett; 2018 May; 15(5):6611-6621. PubMed ID: 29725407
[TBL] [Abstract][Full Text] [Related]
8. The combination therapy of salinomycin and gefitinib using poly(d,l-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles for targeting both lung cancer stem cells and cancer cells.
Zhang Y; Zhang Q; Sun J; Liu H; Li Q
Onco Targets Ther; 2017; 10():5653-5666. PubMed ID: 29225473
[TBL] [Abstract][Full Text] [Related]
9. EGFR-targeting peptide conjugated polymer-lipid hybrid nanoparticles for delivery of salinomycin to osteosarcoma.
Du L; Xu Y; Han B; Wang Y; Zeng Q; Shao M; Yu Z
J Cancer Res Ther; 2023 Dec; 19(6):1544-1551. PubMed ID: 38156920
[TBL] [Abstract][Full Text] [Related]
10. Lipid-polymer nanoparticles with CD133 aptamers for targeted delivery of all-trans retinoic acid to osteosarcoma initiating cells.
Gui K; Zhang X; Chen F; Ge Z; Zhang S; Qi X; Sun J; Yu Z
Biomed Pharmacother; 2019 Mar; 111():751-764. PubMed ID: 30612000
[TBL] [Abstract][Full Text] [Related]
11. Codelivery of salinomycin and docetaxel using poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles to target both gastric cancer cells and cancer stem cells.
Li L; Cui D; Ye L; Li Y; Zhu L; Yang L; Bai B; Nie Z; Gao J; Cao Y
Anticancer Drugs; 2017 Oct; 28(9):989-1001. PubMed ID: 28692437
[TBL] [Abstract][Full Text] [Related]
12. Promoted delivery of salinomycin sodium to lung cancer cells by dual targeting PLGA hybrid nanoparticles.
Zhou J; Sun J; Chen H; Peng Q
Int J Oncol; 2018 Sep; 53(3):1289-1300. PubMed ID: 30015824
[TBL] [Abstract][Full Text] [Related]
13. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells.
Zhou J; Sun M; Jin S; Fan L; Zhu W; Sui X; Cao L; Yang C; Han C
Drug Deliv; 2019 Dec; 26(1):281-289. PubMed ID: 30880491
[TBL] [Abstract][Full Text] [Related]
14. The promotion of salinomycin delivery to hepatocellular carcinoma cells through EGFR and CD133 aptamers conjugation by PLGA nanoparticles.
Jiang J; Chen H; Yu C; Zhang Y; Chen M; Tian S; Sun C
Nanomedicine (Lond); 2015 Jul; 10(12):1863-79. PubMed ID: 26139123
[TBL] [Abstract][Full Text] [Related]
15. Salinomycin may inhibit the cancer stem-like populations with increased chemoradioresistance that nasopharyngeal cancer tumorspheres contain.
Zhang G; Zhang S; Ren J; Yao C; Zhao Z; Qi X; Zhang X; Wang S; Li L
Oncol Lett; 2018 Aug; 16(2):2495-2500. PubMed ID: 30013643
[TBL] [Abstract][Full Text] [Related]
16. The effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cells.
Yao HJ; Zhang YG; Sun L; Liu Y
Biomaterials; 2014 Nov; 35(33):9208-23. PubMed ID: 25115788
[TBL] [Abstract][Full Text] [Related]
17. Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells.
Huang X; Huang J; Leng D; Yang S; Yao Q; Sun J; Hu J
World J Surg Oncol; 2017 Aug; 15(1):167. PubMed ID: 28854941
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Characterization of Salinomycin-Loaded High-Density Lipoprotein and Its Effects on Cervical Cancer Cells and Cervical Cancer Stem Cells.
Yin X; Lu Y; Zou M; Wang L; Zhou X; Zhang Y; Su M
Int J Nanomedicine; 2021; 16():6367-6382. PubMed ID: 34584409
[TBL] [Abstract][Full Text] [Related]
19. Design of naturally inspired jellyfish-shaped cyclopolylactides to manage osteosarcoma cancer stem cells fate.
Liénard R; Montesi M; Panseri S; Dozio SM; Vento F; Mineo PG; Piperno A; De Winter J; Coulembier O; Scala A
Mater Sci Eng C Mater Biol Appl; 2020 Dec; 117():111291. PubMed ID: 32919652
[TBL] [Abstract][Full Text] [Related]
20. Combined nanomedicines targeting colorectal cancer stem cells and cancer cells.
Tsakiris N; Fauvet F; Ruby S; Puisieux A; Paquot A; Muccioli GG; Vigneron AM; Préat V
J Control Release; 2020 Oct; 326():387-395. PubMed ID: 32702392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
